Independent research confirms superiority of midkine combined with conventional cancer markers Sep. 8, 2009
Florpiramine F 18 displays potential utility as an imaging biomarker in AD; phase II data disclosed July 23, 2009
Axis-Shield and Hansa sign global agreement for exclusive rights to sepsis diagnostic assay June 16, 2009
Synairgen reports preliminary findings from phase I trial of IFN-beta biomarker neopterin April 6, 2009
RSS